Form 4: Agilon Health CFO Acquires Shares

Agilon Health's Chief Financial Officer, Jeffrey A. Schwaneke, acquired 2,311 shares of common stock on July 1, 2026, through a net settlement of restricted stock units to cover tax obligations.

Summary

• Jeffrey A. Schwaneke, Chief Financial Officer of Agilon Health, Inc., acquired 2,311 shares of common stock on July 1, 2026.
• This acquisition was a result of shares being withheld by the issuer to satisfy income tax withholding and remittance obligations related to the net settlement of restricted stock units.
• The transaction code was 'F', indicating a forfeiture or withholding.
• The price per share for this transaction was $111.74.
• Following this transaction, Mr. Schwaneke beneficially owns 138,031 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction for tax settlement and does not provide new financial information or strategic insights.

Positives

• The Chief Financial Officer continues to hold a significant number of shares (138,031) in the company, indicating continued confidence.
• The acquisition is a standard procedure for settling restricted stock units and covering tax liabilities, suggesting normal operational activity.

Negatives

• The filing does not explicitly detail any negative financial performance or operational challenges.

Risks

• The filing does not explicitly mention any current issues or potential future challenges.

Future Outlook

This filing is a statement of changes in beneficial ownership and does not contain forward-looking statements or guidance regarding future financial performance.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. The acquisition of shares by a CFO, even if for tax settlement, is a common event and typically reflects standard compensation practices rather than a strategic shift.

Stakeholder Impact

• Shareholders: The transaction is a standard settlement of restricted stock units and does not represent a new purchase or sale of shares by management, thus having a neutral immediate impact on shareholder perception of ownership.

Next Steps

• No specific next steps are mentioned in this filing.

Key Dates

Keywords

Form 4, SEC Filing, Insider Transaction, Agilon Health, AGL, Stock Acquisition, Restricted Stock Units, Tax Withholding, Chief Financial Officer, Jeffrey A. Schwaneke